Status:
RECRUITING
Assessing Systemic Circulation and LV Performance in Adults
Lead Sponsor:
University of Calgary
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background There are significant limitations in the current approaches to assessing 2 important areas of cardiovascular physiology - the systemic circulation and left ventricular (LV) performance. The...
Detailed Description
Background There are significant limitations in our current approaches to assessing 2 important areas of cardiovascular physiology - the systemic circulation and left ventricular (LV) performance. Usi...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Clinical heart failure (HFrEF or HFpEF) for heart failure patients and no clinical heart failure for the non-heart failure participants.
Exclusion
- Unable or unwilling to provide informed consent
- On intravenous inotrope or pressor medications to maintain their cardiac function
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04347655
Start Date
September 15 2021
End Date
December 31 2026
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N 4Z6